Ophthalmology, Cornea and External Diseases Specialist · Tacoma, WA
NPI
1083988851
Since 2012
Specialty
Ophthalmology, Cornea and External Diseases Specialist
Code 207WX0120X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
9040 Jackson Ave
Tacoma, WA, 98431
Phone (253) 968-1670
Groups this clinician bills Medicare through
Medicare paid, 2024
$206K
2,126 services
Medicare patients, 2024
603
Average age 77
Drug cost, 2024
$1.3M
2,418 prescriptions
Company payments, 2025
$261
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Joshua R Roe was code 99214 (office e&m - established), 1,010 times for 537 patients. In total Joshua R Roe billed 2,126 services in 55 codes, and Medicare paid $206K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-11-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,010 | 537 | $87.89 | $89K |
| 92133 Computerized Ophthalmic Imaging | Office | 144 | 143 | $22.37 | $3,221 |
| 92083 Vision, Hearing, and Speech Services | Office | 141 | 134 | $42.73 | $6,025 |
| 76514 Ultrasound - Nonspecific | Office | 125 | 97 | $7.65 | $956 |
| 92025 Test - Miscellaneous | Office | 104 | 83 | $26.19 | $2,723 |
| 92250 Angiography | Office | 97 | 95 | $23.00 | $2,231 |
| 99215 Office E&M - Established | Office | 86 | 78 | $130.43 | $11K |
| 65756 Eye | Facility | 44 | 35 | $890.95 | $39K |
| 92136 Ultrasound - Nonspecific | Office | 43 | 14 | $18.49 | $795 |
| 99204 Office E&M - New | Office | 37 | 37 | $104.87 | $3,880 |
| 92071 Ophthalmological E&M | Office | 34 | 13 | $29.34 | $997 |
| 99213 Office E&M - Established | Office | 33 | 24 | $63.67 | $2,101 |
| 65778 Eye | Office | 15 | 13 | $795.34 | $12K |
| 66984 Cataract Surgery | Facility | 15 | 11 | $381.36 | $5,720 |
| 99205 Office E&M - New | Office | 14 | 14 | $172.22 | $2,411 |
By year: 2023 $99K for 1,045 services; 2024 $206K for 2,126 services.
Medicare prescription drug claims, 2024
In 2024, the drug Joshua R Roe prescribed most often to Medicare patients was Latanoprost, with 390 prescriptions and refills. In total Joshua R Roe wrote 2,418 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Latanoprost Generic | 390 | 1,021 | 150 | $5,480 |
| Prednisolone Acetate Generic | 339 | 492 | 163 | $21K |
| Valacyclovir Valacyclovir Hcl | 289 | 478 | 92 | $30K |
| Tobramycin Generic | 172 | 180 | 108 | $1,027 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 156 | 394 | 51 | $2,977 |
| Lumigan Bimatoprost | 131 | 343 | 51 | $97K |
| Timolol Maleate Generic | 130 | 334 | 60 | $2,535 |
| Moxifloxacin Moxifloxacin Hcl | 94 | 102 | 32 | $3,219 |
| Loteprednol Etabonate Generic | 88 | 160 | 35 | $14K |
| Brimonidine Tartrate Generic | 85 | 199 | 31 | $2,353 |
| Dorzolamide Hcl Generic | 57 | 142 | 24 | $1,241 |
| Restasis Cyclosporine | 56 | 130 | 26 | $80K |
| Brimonidine Tartrate-Timolol Brimonidine Tartrate/Timolol | 47 | 94 | 12 | $6,977 |
| Erythromycin Erythromycin Base | 47 | 49 | 26 | $551 |
| Rocklatan Netarsudil Mesylat/Latanoprost | 42 | 89 | 13 | $37K |
Brand drugs: 1,000 claims; generic drugs: 1,418 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Joshua R Roe $261 ($261 in general payments such as food, travel and fees) from 7 companies. The largest payer was Glaukos Corporation with $68.02.
| Company | Payments | Amount |
|---|---|---|
| Glaukos Corporation GKOS | 2 | $68.02 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 2 | $46.75 |
| Dompe US, Inc. | 2 | $43.73 |
| Harrow Eye, LLC | 2 | $37.05 |
| Genentech USA, Inc. ROG.SW | 1 | $22.83 |
| Tarsus Pharmaceuticals, Inc. TARS | 1 | $21.82 |
| Biotissue Holdings Inc. | 1 | $20.89 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.